Jianfeng Xu

发表

Statistical evidence for high‐penetrance MODY‐causing genes in a large population‐based cohort

M. Udler, L. Billings, T. Pollin, 2022, Endocrinology, diabetes & metabolism.

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

B. Helfand, P. Hulick, L. Billings, 2022, International journal of cardiology. Heart & vasculature.

Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.

B. Helfand, P. Hulick, S. Krantz, 2023, Clinical lung cancer.

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

J. Schleutker, Jianfeng Xu, Z. Mo, 2017, Scientific Reports.

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

K. D. Sørensen, Ali Amin Al Olama, Lilit C Moss, 2021, Nature Genetics.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2018, Nature Communications.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2019, Nature Genetics.

Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry

K. Cooney, P. Walsh, W. Isaacs, 2022, The Prostate.

Screening for deafness-associated mitochondrial 12S rRNA mutations by using a multiplex allele-specific PCR method

Yu Ding, Xiaojiang Lin, Lei Huai, 2020, Bioscience reports.

Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort

B. Helfand, A. Glaser, James T. Kearns, 2022, BJUI compass.

Assessing the performance of genetic risk score for stratifying risk of post-sepsis cardiovascular complications

S. Zheng, B. Helfand, Zhuqing Shi, 2023, Frontiers in Cardiovascular Medicine.

D. Duggan, B. Helfand, Z. Mo, 2019 .

Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values

D. Duggan, Jianfeng Xu, W. Isaacs, 2019, The Prostate.

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.

K. D. Sørensen, J. Witte, D. Schaid, 2023, American journal of human genetics.

Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.

D. Duggan, S. Zheng, B. Helfand, 2023, Thrombosis research.

Association of sickle cell trait with adverse pregnancy outcomes in a population‐based cohort

B. Helfand, M. Caplan, J. Morgan, 2023, Acta obstetricia et gynecologica Scandinavica.

Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry

K. D. Sørensen, J. Witte, D. Schaid, 2023, medRxiv.

Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.

S. Zheng, B. Helfand, P. Hulick, 2023, The Journal of clinical endocrinology and metabolism.

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

K. D. Sørensen, H. Ostrer, T. Sellers, 2018, Nature Communications.

Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.

D. Duggan, S. Zheng, B. Helfand, 2023, Journal of Alzheimer's disease : JAD.

Analysis of gene mutations in PKD1/PKD2 by multiplex ligation-dependent probe amplification: some new findings

J. Qi, Guopeng Yu, Xiaoqiang Qian, 2015, Renal failure.